From December 8 to 11, 2026, the Motor Neuron Disease Association ( MNDA) will hold its International ALS/MND Symposium in Amsterdam. As part of the conference , the “ALS App Europe Initiative” will host a satellite meeting on December 8, supported by APST.
`The ALS App Europe Initiative` aims to further develop the digital tracking and assessment of the progression of amyotrophic lateral sclerosis (ALS) across Europe. By connecting European ALS centers and utilizing digital applications, the initiative aims to involve patients more closely in the monitoring of their condition and to support clinical care and ALS research.
New Developments in Digital ALS Research and Care
The meeting will focus on five current developments:
- ALS-OPM 3.3: Further development of standardized assessment of motor ALS phenotypes in European ALS centers.
- ALSFRS-R-SE 2.1: Introduction of a revised, self-explanatory version of the ALSFRS-R questionnaire for assessing physical functioning in multiple languages.
- ALS App: New features for independent tracking of disease progression and the use of data in research.
- ALS Center App: A digital link between ALS centers and the disease progression data collected from patients outside the outpatient clinic.
- ALS Pen: Presentation of the current status of a study on the quantitative assessment of hand motor function, particularly finger strength and thumb mobility, using the ALS Pen.
The developments presented are intended to help track changes in ALS more accurately and regularly and to improve collaboration between patients, ALS treatment centers, and the research community. The meeting is aimed specifically at healthcare professionals, researchers, and partners in European ALS care.
APST is supporting the satellite meeting and is committed to the further development of digital solutions to improve care for people with ALS.
We look forward to the professional exchange in Amsterdam and will report on important developments in the “ALS App Europe Initiative.”

